Global (United States, European Union and China) Clot Management Devices

Clot Management Devices Comprehensive Study by Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices {Mechanical Thrombectomy, Aspiration Thrombectomy, Percutaneous Mechanical Thrombectomy}, Catheter-Directed Thrombolysis Devices, Inferior Vena Cava Filters {Permanent,Retrievable}), Application (Hospitals, Diagnostic Centres, Others) Players and Region - Global Market Outlook to 2027

Clot Management Devices Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 4.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Clot Management Devices Market Overview:
Clot Management Devices is an equipment that used to clear the blockage of blood supply to the hearts, brains, legs and others. Clot Management Devices market is expected to mark significant growth over forecasted period owing to increasing government spending on healthcare infrastructure, growing geriatric population and technological advancement. There has been significant rise in diagnosis and treatment of VTE with figure stood up to USD 15.5 Billion in United States alone in 2018, the future for clot management devices looks promising. This result in rising popularity of clot management procedures for rural population, increasing demand of unmet medical and healthcare needs and escalating need of research and development may trigger demand and help in industry expansion. As per latest study released by AMA Research, the Global Clot Management Devices market is expected to see growth rate of 4.3% and may see market size of USD1246.0 Million by 2027.

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
High Growth MarketAsia Pacific
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Clot Management Devices Market Dynamics:
AttributesDetails
Growth Drivers
  • Increase Number of Patients with Clots in Cardiovascular and Peripherals Vascular Systems Boost the Market.
  • Increase Awareness about VTE Fuelled Up the Clot Management Devices.
Restraints
  • Increase in Risk of Bleeding and Blockage Hampers the Devices.
  • Lack of Trained Professional and Physician to Use the Clot Management Device.
Road Blocks / Challenges
  • Limitation Due to Reimbursements in Developing Countries are Anticipated to Challenge the Market.
  • Stringent Government Regulation Restrain the Market.
Gaps & Opportunities
  • Proliferation of Healthcare Infrastructure Leads to Grow the Clot Management Devices Market.
  • Upsurge Demand of Advanced Technologies Based Clot Management Devices.


Competitive Landscape:

Some of the key players profiled in the report are Angio Dynamics, Inc. (United States), Applied Medical Resources Corporation (United States), Bayer HealthCare AG (Germany), Boston Scientific Corporation (United States), Edwards Lifesciences Corporation (United States), EKOS Corporation (United States), Janssen Pharmaceuticals, Inc. (United States), Medtronic, Inc. (United States), Stryker Corporation (United States) and Volcano Corporation (United States). Additionally, following companies can also be profiled that are part of our coverage like Johnson & Johnson Services Inc. (United States), Sorin Group (Italy), Bayer AG (Germany) and Abbott (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Clot Management Devices market by 2027.

Latest Market Insights:
In September 2018, LeMaitre Vascular acquired vascular clot management business of Applied Medical Resources Corporation with a deal of 14.2 USD Millions. This acquisition is beneficial in providing clot management product line that consist of Syntel embolectomy, thrombectomy catheters and irrigation catheters.

In January 2019, Johnson & Johnson Medical Devices launched a Registry to Study Stroke-Inducing Blood Clots that removed by thrombectomy which is beneficial in offers a broad portfolio of devices that applicable for endovascular treatment of hemorrhagic and ischemic stroke.

“According to US Food and Drug Administration, its cleared that the use of the Trevo clot retrieval device to treat certain stroke patients up to 24 hours after symptom onset, expanding the device’s indication to a broader group of patients. It also expands the treatment window from 6 to 24 hours that will significantly increase the number of stroke patients who may benefit from treatment.”

What Can be Explored with the Clot Management Devices Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Clot Management Devices Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Clot Management Devices
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Clot Management Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Clot Management Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Clot Management Devices Manufacturers, Clot Management Devices Traders, End-Use Market Participants of Different Segments of Clot Management Devices, Government and Research Organizations, R&D Institutions and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices {Mechanical Thrombectomy, Aspiration Thrombectomy, Percutaneous Mechanical Thrombectomy}
  • Catheter-Directed Thrombolysis Devices
  • Inferior Vena Cava Filters {Permanent,Retrievable}
By Application
  • Hospitals
  • Diagnostic Centres
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase Number of Patients with Clots in Cardiovascular and Peripherals Vascular Systems Boost the Market.
      • 3.2.2. Increase Awareness about VTE Fuelled Up the Clot Management Devices.
    • 3.3. Market Challenges
      • 3.3.1. Limitation Due to Reimbursements in Developing Countries are Anticipated to Challenge the Market.
      • 3.3.2. Stringent Government Regulation Restrain the Market.
    • 3.4. Market Trends
      • 3.4.1. Rise in advanced healthcare facilities.
      • 3.4.2. High economic developments expected the boost the market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clot Management Devices, by Type, Application and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Clot Management Devices (Value)
      • 5.2.1. Global Clot Management Devices by: Type (Value)
        • 5.2.1.1. Neurovascular Embolectomy Devices
        • 5.2.1.2. Embolectomy Balloon Catheters
        • 5.2.1.3. Percutaneous Thrombectomy Devices {Mechanical Thrombectomy, Aspiration Thrombectomy, Percutaneous Mechanical Thrombectomy}
        • 5.2.1.4. Catheter-Directed Thrombolysis Devices
        • 5.2.1.5. Inferior Vena Cava Filters {Permanent,Retrievable}
      • 5.2.2. Global Clot Management Devices by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Diagnostic Centres
        • 5.2.2.3. Others
      • 5.2.3. Global Clot Management Devices Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Clot Management Devices (Price)
      • 5.3.1. Global Clot Management Devices by: Type (Price)
  • 6. Clot Management Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Angio Dynamics, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Applied Medical Resources Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer HealthCare AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Edwards Lifesciences Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. EKOS Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Janssen Pharmaceuticals, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medtronic, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Stryker Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Volcano Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clot Management Devices Sale, by Type, Application and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Clot Management Devices (Value)
      • 7.2.1. Global Clot Management Devices by: Type (Value)
        • 7.2.1.1. Neurovascular Embolectomy Devices
        • 7.2.1.2. Embolectomy Balloon Catheters
        • 7.2.1.3. Percutaneous Thrombectomy Devices {Mechanical Thrombectomy, Aspiration Thrombectomy, Percutaneous Mechanical Thrombectomy}
        • 7.2.1.4. Catheter-Directed Thrombolysis Devices
        • 7.2.1.5. Inferior Vena Cava Filters {Permanent,Retrievable}
      • 7.2.2. Global Clot Management Devices by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Diagnostic Centres
        • 7.2.2.3. Others
      • 7.2.3. Global Clot Management Devices Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Clot Management Devices (Price)
      • 7.3.1. Global Clot Management Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clot Management Devices: by Type(USD Million)
  • Table 2. Clot Management Devices Neurovascular Embolectomy Devices , by Region USD Million (2016-2021)
  • Table 3. Clot Management Devices Embolectomy Balloon Catheters , by Region USD Million (2016-2021)
  • Table 4. Clot Management Devices Percutaneous Thrombectomy Devices {Mechanical Thrombectomy, Aspiration Thrombectomy, Percutaneous Mechanical Thrombectomy} , by Region USD Million (2016-2021)
  • Table 5. Clot Management Devices Catheter-Directed Thrombolysis Devices , by Region USD Million (2016-2021)
  • Table 6. Clot Management Devices Inferior Vena Cava Filters {Permanent,Retrievable} , by Region USD Million (2016-2021)
  • Table 7. Clot Management Devices: by Application(USD Million)
  • Table 8. Clot Management Devices Hospitals , by Region USD Million (2016-2021)
  • Table 9. Clot Management Devices Diagnostic Centres , by Region USD Million (2016-2021)
  • Table 10. Clot Management Devices Others , by Region USD Million (2016-2021)
  • Table 11. South America Clot Management Devices, by Country USD Million (2016-2021)
  • Table 12. South America Clot Management Devices, by Type USD Million (2016-2021)
  • Table 13. South America Clot Management Devices, by Application USD Million (2016-2021)
  • Table 14. Brazil Clot Management Devices, by Type USD Million (2016-2021)
  • Table 15. Brazil Clot Management Devices, by Application USD Million (2016-2021)
  • Table 16. Argentina Clot Management Devices, by Type USD Million (2016-2021)
  • Table 17. Argentina Clot Management Devices, by Application USD Million (2016-2021)
  • Table 18. Rest of South America Clot Management Devices, by Type USD Million (2016-2021)
  • Table 19. Rest of South America Clot Management Devices, by Application USD Million (2016-2021)
  • Table 20. Asia Pacific Clot Management Devices, by Country USD Million (2016-2021)
  • Table 21. Asia Pacific Clot Management Devices, by Type USD Million (2016-2021)
  • Table 22. Asia Pacific Clot Management Devices, by Application USD Million (2016-2021)
  • Table 23. China Clot Management Devices, by Type USD Million (2016-2021)
  • Table 24. China Clot Management Devices, by Application USD Million (2016-2021)
  • Table 25. Japan Clot Management Devices, by Type USD Million (2016-2021)
  • Table 26. Japan Clot Management Devices, by Application USD Million (2016-2021)
  • Table 27. India Clot Management Devices, by Type USD Million (2016-2021)
  • Table 28. India Clot Management Devices, by Application USD Million (2016-2021)
  • Table 29. South Korea Clot Management Devices, by Type USD Million (2016-2021)
  • Table 30. South Korea Clot Management Devices, by Application USD Million (2016-2021)
  • Table 31. Taiwan Clot Management Devices, by Type USD Million (2016-2021)
  • Table 32. Taiwan Clot Management Devices, by Application USD Million (2016-2021)
  • Table 33. Australia Clot Management Devices, by Type USD Million (2016-2021)
  • Table 34. Australia Clot Management Devices, by Application USD Million (2016-2021)
  • Table 35. Rest of Asia-Pacific Clot Management Devices, by Type USD Million (2016-2021)
  • Table 36. Rest of Asia-Pacific Clot Management Devices, by Application USD Million (2016-2021)
  • Table 37. Europe Clot Management Devices, by Country USD Million (2016-2021)
  • Table 38. Europe Clot Management Devices, by Type USD Million (2016-2021)
  • Table 39. Europe Clot Management Devices, by Application USD Million (2016-2021)
  • Table 40. Germany Clot Management Devices, by Type USD Million (2016-2021)
  • Table 41. Germany Clot Management Devices, by Application USD Million (2016-2021)
  • Table 42. France Clot Management Devices, by Type USD Million (2016-2021)
  • Table 43. France Clot Management Devices, by Application USD Million (2016-2021)
  • Table 44. Italy Clot Management Devices, by Type USD Million (2016-2021)
  • Table 45. Italy Clot Management Devices, by Application USD Million (2016-2021)
  • Table 46. United Kingdom Clot Management Devices, by Type USD Million (2016-2021)
  • Table 47. United Kingdom Clot Management Devices, by Application USD Million (2016-2021)
  • Table 48. Netherlands Clot Management Devices, by Type USD Million (2016-2021)
  • Table 49. Netherlands Clot Management Devices, by Application USD Million (2016-2021)
  • Table 50. Rest of Europe Clot Management Devices, by Type USD Million (2016-2021)
  • Table 51. Rest of Europe Clot Management Devices, by Application USD Million (2016-2021)
  • Table 52. MEA Clot Management Devices, by Country USD Million (2016-2021)
  • Table 53. MEA Clot Management Devices, by Type USD Million (2016-2021)
  • Table 54. MEA Clot Management Devices, by Application USD Million (2016-2021)
  • Table 55. Middle East Clot Management Devices, by Type USD Million (2016-2021)
  • Table 56. Middle East Clot Management Devices, by Application USD Million (2016-2021)
  • Table 57. Africa Clot Management Devices, by Type USD Million (2016-2021)
  • Table 58. Africa Clot Management Devices, by Application USD Million (2016-2021)
  • Table 59. North America Clot Management Devices, by Country USD Million (2016-2021)
  • Table 60. North America Clot Management Devices, by Type USD Million (2016-2021)
  • Table 61. North America Clot Management Devices, by Application USD Million (2016-2021)
  • Table 62. United States Clot Management Devices, by Type USD Million (2016-2021)
  • Table 63. United States Clot Management Devices, by Application USD Million (2016-2021)
  • Table 64. Canada Clot Management Devices, by Type USD Million (2016-2021)
  • Table 65. Canada Clot Management Devices, by Application USD Million (2016-2021)
  • Table 66. Mexico Clot Management Devices, by Type USD Million (2016-2021)
  • Table 67. Mexico Clot Management Devices, by Application USD Million (2016-2021)
  • Table 68. Clot Management Devices: by Type(USD/Units)
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Clot Management Devices: by Type(USD Million)
  • Table 80. Clot Management Devices Neurovascular Embolectomy Devices , by Region USD Million (2022-2027)
  • Table 81. Clot Management Devices Embolectomy Balloon Catheters , by Region USD Million (2022-2027)
  • Table 82. Clot Management Devices Percutaneous Thrombectomy Devices {Mechanical Thrombectomy, Aspiration Thrombectomy, Percutaneous Mechanical Thrombectomy} , by Region USD Million (2022-2027)
  • Table 83. Clot Management Devices Catheter-Directed Thrombolysis Devices , by Region USD Million (2022-2027)
  • Table 84. Clot Management Devices Inferior Vena Cava Filters {Permanent,Retrievable} , by Region USD Million (2022-2027)
  • Table 85. Clot Management Devices: by Application(USD Million)
  • Table 86. Clot Management Devices Hospitals , by Region USD Million (2022-2027)
  • Table 87. Clot Management Devices Diagnostic Centres , by Region USD Million (2022-2027)
  • Table 88. Clot Management Devices Others , by Region USD Million (2022-2027)
  • Table 89. South America Clot Management Devices, by Country USD Million (2022-2027)
  • Table 90. South America Clot Management Devices, by Type USD Million (2022-2027)
  • Table 91. South America Clot Management Devices, by Application USD Million (2022-2027)
  • Table 92. Brazil Clot Management Devices, by Type USD Million (2022-2027)
  • Table 93. Brazil Clot Management Devices, by Application USD Million (2022-2027)
  • Table 94. Argentina Clot Management Devices, by Type USD Million (2022-2027)
  • Table 95. Argentina Clot Management Devices, by Application USD Million (2022-2027)
  • Table 96. Rest of South America Clot Management Devices, by Type USD Million (2022-2027)
  • Table 97. Rest of South America Clot Management Devices, by Application USD Million (2022-2027)
  • Table 98. Asia Pacific Clot Management Devices, by Country USD Million (2022-2027)
  • Table 99. Asia Pacific Clot Management Devices, by Type USD Million (2022-2027)
  • Table 100. Asia Pacific Clot Management Devices, by Application USD Million (2022-2027)
  • Table 101. China Clot Management Devices, by Type USD Million (2022-2027)
  • Table 102. China Clot Management Devices, by Application USD Million (2022-2027)
  • Table 103. Japan Clot Management Devices, by Type USD Million (2022-2027)
  • Table 104. Japan Clot Management Devices, by Application USD Million (2022-2027)
  • Table 105. India Clot Management Devices, by Type USD Million (2022-2027)
  • Table 106. India Clot Management Devices, by Application USD Million (2022-2027)
  • Table 107. South Korea Clot Management Devices, by Type USD Million (2022-2027)
  • Table 108. South Korea Clot Management Devices, by Application USD Million (2022-2027)
  • Table 109. Taiwan Clot Management Devices, by Type USD Million (2022-2027)
  • Table 110. Taiwan Clot Management Devices, by Application USD Million (2022-2027)
  • Table 111. Australia Clot Management Devices, by Type USD Million (2022-2027)
  • Table 112. Australia Clot Management Devices, by Application USD Million (2022-2027)
  • Table 113. Rest of Asia-Pacific Clot Management Devices, by Type USD Million (2022-2027)
  • Table 114. Rest of Asia-Pacific Clot Management Devices, by Application USD Million (2022-2027)
  • Table 115. Europe Clot Management Devices, by Country USD Million (2022-2027)
  • Table 116. Europe Clot Management Devices, by Type USD Million (2022-2027)
  • Table 117. Europe Clot Management Devices, by Application USD Million (2022-2027)
  • Table 118. Germany Clot Management Devices, by Type USD Million (2022-2027)
  • Table 119. Germany Clot Management Devices, by Application USD Million (2022-2027)
  • Table 120. France Clot Management Devices, by Type USD Million (2022-2027)
  • Table 121. France Clot Management Devices, by Application USD Million (2022-2027)
  • Table 122. Italy Clot Management Devices, by Type USD Million (2022-2027)
  • Table 123. Italy Clot Management Devices, by Application USD Million (2022-2027)
  • Table 124. United Kingdom Clot Management Devices, by Type USD Million (2022-2027)
  • Table 125. United Kingdom Clot Management Devices, by Application USD Million (2022-2027)
  • Table 126. Netherlands Clot Management Devices, by Type USD Million (2022-2027)
  • Table 127. Netherlands Clot Management Devices, by Application USD Million (2022-2027)
  • Table 128. Rest of Europe Clot Management Devices, by Type USD Million (2022-2027)
  • Table 129. Rest of Europe Clot Management Devices, by Application USD Million (2022-2027)
  • Table 130. MEA Clot Management Devices, by Country USD Million (2022-2027)
  • Table 131. MEA Clot Management Devices, by Type USD Million (2022-2027)
  • Table 132. MEA Clot Management Devices, by Application USD Million (2022-2027)
  • Table 133. Middle East Clot Management Devices, by Type USD Million (2022-2027)
  • Table 134. Middle East Clot Management Devices, by Application USD Million (2022-2027)
  • Table 135. Africa Clot Management Devices, by Type USD Million (2022-2027)
  • Table 136. Africa Clot Management Devices, by Application USD Million (2022-2027)
  • Table 137. North America Clot Management Devices, by Country USD Million (2022-2027)
  • Table 138. North America Clot Management Devices, by Type USD Million (2022-2027)
  • Table 139. North America Clot Management Devices, by Application USD Million (2022-2027)
  • Table 140. United States Clot Management Devices, by Type USD Million (2022-2027)
  • Table 141. United States Clot Management Devices, by Application USD Million (2022-2027)
  • Table 142. Canada Clot Management Devices, by Type USD Million (2022-2027)
  • Table 143. Canada Clot Management Devices, by Application USD Million (2022-2027)
  • Table 144. Mexico Clot Management Devices, by Type USD Million (2022-2027)
  • Table 145. Mexico Clot Management Devices, by Application USD Million (2022-2027)
  • Table 146. Clot Management Devices: by Type(USD/Units)
  • Table 147. Research Programs/Design for This Report
  • Table 148. Key Data Information from Secondary Sources
  • Table 149. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clot Management Devices: by Type USD Million (2016-2021)
  • Figure 5. Global Clot Management Devices: by Application USD Million (2016-2021)
  • Figure 6. South America Clot Management Devices Share (%), by Country
  • Figure 7. Asia Pacific Clot Management Devices Share (%), by Country
  • Figure 8. Europe Clot Management Devices Share (%), by Country
  • Figure 9. MEA Clot Management Devices Share (%), by Country
  • Figure 10. North America Clot Management Devices Share (%), by Country
  • Figure 11. Global Clot Management Devices: by Type USD/Units (2016-2021)
  • Figure 12. Global Clot Management Devices share by Players 2021 (%)
  • Figure 13. Global Clot Management Devices share by Players (Top 3) 2021(%)
  • Figure 14. Global Clot Management Devices share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Angio Dynamics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Angio Dynamics, Inc. (United States) Revenue: by Geography 2021
  • Figure 18. Applied Medical Resources Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Applied Medical Resources Corporation (United States) Revenue: by Geography 2021
  • Figure 20. Bayer HealthCare AG (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Bayer HealthCare AG (Germany) Revenue: by Geography 2021
  • Figure 22. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 24. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2021
  • Figure 26. EKOS Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. EKOS Corporation (United States) Revenue: by Geography 2021
  • Figure 28. Janssen Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Janssen Pharmaceuticals, Inc. (United States) Revenue: by Geography 2021
  • Figure 30. Medtronic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Medtronic, Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Stryker Corporation (United States) Revenue: by Geography 2021
  • Figure 34. Volcano Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Volcano Corporation (United States) Revenue: by Geography 2021
  • Figure 36. Global Clot Management Devices: by Type USD Million (2022-2027)
  • Figure 37. Global Clot Management Devices: by Application USD Million (2022-2027)
  • Figure 38. South America Clot Management Devices Share (%), by Country
  • Figure 39. Asia Pacific Clot Management Devices Share (%), by Country
  • Figure 40. Europe Clot Management Devices Share (%), by Country
  • Figure 41. MEA Clot Management Devices Share (%), by Country
  • Figure 42. North America Clot Management Devices Share (%), by Country
  • Figure 43. Global Clot Management Devices: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Angio Dynamics, Inc. (United States)
  • Applied Medical Resources Corporation (United States)
  • Bayer HealthCare AG (Germany)
  • Boston Scientific Corporation (United States)
  • Edwards Lifesciences Corporation (United States)
  • EKOS Corporation (United States)
  • Janssen Pharmaceuticals, Inc. (United States)
  • Medtronic, Inc. (United States)
  • Stryker Corporation (United States)
  • Volcano Corporation (United States)
Additional players considered in the study are as follows:
Johnson & Johnson Services Inc. (United States) , Sorin Group (Italy) , Bayer AG (Germany) , Abbott (United States) ,
Select User Access Type

Key Highlights of Report


Aug 2022 162 Pages 80 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Clot Management Devices Quantitative research analysis
Global (United States, European Union and China) Clot Management Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Clot Management Devices market are Angio Dynamics, Inc. (United States), Applied Medical Resources Corporation (United States), Bayer HealthCare AG (Germany), Boston Scientific Corporation (United States), Edwards Lifesciences Corporation (United States), EKOS Corporation (United States), Janssen Pharmaceuticals, Inc. (United States), Medtronic, Inc. (United States), Stryker Corporation (United States) and Volcano Corporation (United States), to name a few.
"Rise in advanced healthcare facilities. " is seen as one of major influencing trends for Clot Management Devices Market during projected period 2021-2027.
Neurovascular Embolectomy Devices segment in Global market to hold robust market share owing to "Increase Number of Patients with Clots in Cardiovascular and Peripherals Vascular Systems Boost the Market. ".
Neurovascular Embolectomy Devices dominated the Clot Management Devices market. This is attributable due to "Increase Number of Patients with Clots in Cardiovascular and Peripherals Vascular Systems Boost the Market. "
Hospitals dominated the Clot Management Devices market. This is attributable to growing trend of "Rise in advanced healthcare facilities. "

Know More About Global (United States, European Union and China) Clot Management Devices Report?

Have a Query? Click Here

Other Related Reports

Coronary Stents Comprehensive Study by Type (Drug-Eluting Stents, Bioabsorbable Stents, Bare Metal Stents), Application (Ambulatory Surgical Centers, Hospitals, Cardiac Centers), Material (Metallic, ...
$ 3450
Duodenal Stent Comprehensive Study by Type (Metal Duodenal Stent, Polymer Duodenal Stent), Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Other Applicati...
$ 3450
Medical Imaging Phantoms Comprehensive Study by Type (X-ray/Fluoroscopy Phantoms, Ultrasound Phantoms, CT Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, Others), Application (Hospitals, Academic &...
$ 3650
Ureteral Access Sheath Comprehensive Study by Application (Hospitals, Clinics), Diameter (Fr < 10, 10<= Fr <13, 13<= Fr <=15) Players and Region - Global Market Outlook to 2024
$ 3500
Cosmetic Lasers Comprehensive Study by Type (Ablative Laser, Non-Ablative Laser), Application (Fine Lines and Wrinkles, Skin Tightening, Pigmented Lesions, Precancerous Lesions, Vascular Lesions, Tat...
$ 3650
Surgical Drapes Comprehensive Study by Type (Incise, Laparoscopy, Laparotomy, Leggings, Lithotomy, Sheets, Others), Application (Surgical Treatment, Sterilization, Others), By End User (Hospitals, Cl...
$ 3750